Today: 30 April 2026
Oracle stock ticks up as Goldman turns bullish; new retail AI supply-chain tool adds focus
12 January 2026
1 min read

Oracle stock ticks up as Goldman turns bullish; new retail AI supply-chain tool adds focus

New York, Jan 12, 2026, 10:16 a.m. EST — Regular session

Oracle shares nudged 0.2% higher to $198.96 in early trading Monday following Goldman Sachs’ initiation of coverage with a Buy rating and a $240 price target. So far, the stock has swung between $194.91 and $199.83 during the session.

The call hits a stock still battling to recover from a steep selloff, driven by concerns over debt and financing linked to Oracle’s AI data-center expansion. Since September 2025, Oracle has dropped over 40%, according to MarketWatch, which cited Deutsche Bank.

Goldman analyst Gabriela Borges highlighted Oracle’s tech advantage in AI computing and forecasted its slice of new cloud revenue jumping from under 10% to roughly 25% over the next three years, Investing.com reported. She cautioned that gross margins might fall short of consensus in the near term but expects them to bounce back as capacity expands.

Oracle highlighted its backlog to prove demand is solid. The company reported $523 billion in remaining performance obligations—signed contracts not yet recognized as revenue—at the close of its fiscal second quarter, a 438% jump.

On Sunday, Oracle introduced Oracle Retail Supply Chain Collaboration at NRF 2026 in New York, rolling out a cloud platform designed to help retailers and suppliers exchange data, oversee compliance, and receive warnings about possible disruptions. Paul Woodward, vice president for Oracle Retail Products, described the challenge retailers face as “a constant battle” to balance supply chains while safeguarding margins. Oracle

Oracle’s latest product push underscores its effort to expand industry-specific solutions as it battles for cloud infrastructure spending against giants like Amazon’s AWS, Microsoft’s Azure, and Google Cloud. The company is banking on specialized tools and AI-driven workloads to prevent customers from making decisions based solely on cost.

The spending bill still hangs over the narrative. Following Oracle’s recent quarterly report, executives revealed that fiscal 2026 capital expenditures would run roughly $15 billion higher than the $35 billion they mentioned back in September. Visible Alpha’s Melissa Otto flagged that the debt issue continues to “cause uncertainty among investors,” Reuters reported. Reuters

Investors are tuning in to Oracle’s pitch to retailers at NRF’s show running through Jan. 13, looking for clues on whether the company can convert demos into actual bookings. For ORCL, any buzz about new orders—or another financing announcement—could shake the stock fast.

Stock Market Today

  • Cartier Heir Sentenced to 8 Years for $470M Drug Money Crypto Laundering Scheme
    April 30, 2026, 3:26 PM EDT. Maximilien de Hoop Cartier, descended from the Cartier jewelry family, was sentenced to eight years in federal prison for running an unlicensed cryptocurrency exchange that laundered over $470 million in drug money. The scheme involved shell companies posing as software firms and broke transactions into smaller amounts to evade bank detection. Cartier pleaded guilty to money transmission without a license and bank fraud conspiracy in Manhattan federal court. Authorities seized nearly $940,000 in 2021, and Cartier was ordered to forfeit over $2.3 million and multiple bank accounts. U.S. Attorney Jay Clayton condemned Cartier's exploitation of financial systems for laundering drug proceeds. Cartier also maintains a social media presence as a singer under the name 'Max Cartier.'

Latest article

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

30 April 2026
Rezolve AI reported $60 million in first-quarter revenue, surpassing its audited 2025 total of $46.8 million, based on unaudited accounts. Shares rose 4.9% after the update. The company reaffirmed its $360 million 2026 revenue target and said it can reach profitability without new equity sales. Commerce.com, which rejected Rezolve’s all-stock takeover offer, adopted a poison pill defense.
Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

30 April 2026
Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

30 April 2026
Stellantis reported a first-quarter net profit of €377 million, reversing a €387 million loss a year earlier, aided by a €400 million expected U.S. tariff refund. Industrial free cash flow remained negative at €1.92 billion. Shares fell 6.4% to €6.22 after the results. CEO Antonio Filosa faces pressure ahead of a May 21 investor day to present a stronger turnaround plan.
Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings
Previous Story

Citigroup stock slides as Trump’s 10% credit-card rate cap plan rattles lenders ahead of earnings

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms
Next Story

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

Go toTop